Coral Laboratories [CORALAB] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Coral Laboratories Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories Ltd. wins in 7 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Coral Laboratories Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 11.06 36.73 Coral Laboratories Ltd.
Price-to-Book Ratio 0.73 5.15 Coral Laboratories Ltd.
Debt-to-Equity Ratio 0.41 6.68 Coral Laboratories Ltd.
PEG Ratio -0.20 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 4.44 23.61 Coral Laboratories Ltd.
Profit Margin (TTM) 15.97% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 5.58% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 5.58% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 12.01% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 10.53% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-41.67M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 0.29% 0.97% Sun Pharmaceutical Industries Ltd.
1-Year Return -18.38% 7.10% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.77 7.05 Coral Laboratories Ltd.
Enterprise Value $532.28M $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 0.61 6.66 Coral Laboratories Ltd.
Gross Profit Margin (TTM) 59.74% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $245 $237 Coral Laboratories Ltd.
Earnings per Share (Diluted) $39.14 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.90 0.11 Sun Pharmaceutical Industries Ltd.

Coral Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

CORALAB
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories Ltd.2.22%0.75%9.98%18.09%9.54%13.35%
Sun Pharmaceutical Industries Ltd.-0.09%0.96%-3.84%1.28%0.50%4.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories Ltd.-18.38%101.77%4.69%9.89%526.74%564.59%
Sun Pharmaceutical Industries Ltd.7.10%82.23%170.41%143.23%656.74%2,541.29%

Performance & Financial Health Analysis: Coral Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricCORALABSUNPHARMA
Market Information
Market Cap i₹1.53B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,5663,903,142
90 Day Avg. Volume i2,8153,253,866
Last Close₹500.65₹1,806.00
52 Week Range₹360.00 - ₹624.95₹1,548.00 - ₹1,916.60
% from 52W High-19.89%-5.77%
All-Time High₹1,190.00 (Jul 24, 2017)₹1,960.35 (Sep 30, 2024)
% from All-Time High-57.93%-7.87%
Growth Metrics
Quarterly Revenue Growth-0.06%0.14%
Quarterly Earnings Growth-0.55%0.16%
Financial Health
Profit Margin (TTM) i0.16%0.19%
Operating Margin (TTM) i0.06%0.26%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i0.416.68
Cash & Liquidity
Book Value per Share (MRQ)₹596.42₹324.46
Cash per Share (MRQ)₹286.45₹115.87
Operating Cash Flow (TTM) i₹106.44M₹110.84B
Levered Free Cash Flow (TTM) i₹241.56M₹109.29B
Dividends
Last 12-Month Dividend Yield i0.29%0.97%
Last 12-Month Dividend i₹1.50₹16.50

Valuation & Enterprise Metrics Analysis: Coral Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricCORALAB (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i11.0636.73
Forward P/E i7.4529.48
PEG Ratio i-0.203.59
Price to Sales (TTM) i1.777.05
Price to Book (MRQ) i0.735.15
Market Capitalization
Market Capitalization i₹1.53B₹3.88T
Enterprise Value i₹532.28M₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i0.616.66
Enterprise to EBITDA i4.4423.61
Risk & Other Metrics
Beta i0.900.11
Book Value per Share (MRQ) i₹596.42₹324.46

Financial Statements Comparison: Coral Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCORALAB (2025)SUNPHARMA (2025)
Revenue/Sales i1.13B520.41B
Cost of Goods Sold i561.92M121.98B
COGS % of Revenue i49.6%23.4%
Gross Profit i569.87M398.44B
Gross Margin i50.4%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i246.11M125.81B
Operating Margin i21.7%24.2%
EBITDA i353.48M167.25B
EBITDA Margin i31.2%32.1%
Pre-Tax Income i324.70M137.52B
Pre-Tax Income % of Revenue i28.7%26.4%
Income Tax i83.15M27.72B
Income Tax % of Revenue i7.3%5.3%
Net Income (Profit) i241.56M109.65B
Profit Margin i21.3%21.1%

Balance Sheet & Liquidity Metrics

MetricCORALAB (2025)SUNPHARMA (2025)
Cash & Equivalents i34.06M102.69B
Total Current Assets i1.77B526.24B
Total Current Assets % of Revenue i156.0%101.1%
Total Current Liabilities i249.58M181.94B
Total Current Liabilities % of Revenue i22.1%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i2.01B724.86B
Retained Earnings i1.71B578.62B
Retained Earnings % of Revenue i151.0%111.2%
Property, Plant & Equipment i217.44M100.36B

Cash Flow Statement Comparison

MetricCORALAB (2025)SUNPHARMA (2025)
Operating Cash Flow i106.44M110.84B
Operating Cash Flow % of Revenue i9.4%21.3%
Capital Expenditures i-29.45M-20.68B
Free Cash Flow i-41.67M119.44B
FCF Margin i-3.7%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricCORALABSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.57M2.40B
Float Shares i802,6091.07B
% Held by Insiders i78.86%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i21.14%15.69%

Dividend Analysis & Yield Comparison: Coral Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricCORALABSUNPHARMA
Last 12-Month Dividend i₹1.50₹16.50
Last 12-Month Dividend Yield i0.29%0.97%
3-Year Avg Annual Dividend i₹1.17₹17.33
3-Year Avg Dividend Yield i0.26%0.51%
3-Year Total Dividends i₹3.50₹52.00
Ex-Dividend DateSep 19, 2025Feb 05, 2026